medigraphic.com
ISSN 2305-7939 (Electronic)

2020, Number 2

<< Back Next >>

RCU 2020; 9 (2)

Mucinous renal tumor

Verdecia VJ, Quintana RM, Garay CSB, González LT

Language: Spanish
References: 16
Page: 68-73
PDF size: 841.73 Kb.


ABSTRACT

Mucinous renal tumors has been diagnosed more in females, and is considered of low grade malignancy. The objective is to describe the clinical, anatomical and pathological aspects of a case with a mucinous renal tumor. A 58 years old mestizo male patient came complaining of left lumbar pain. Imaging studies reported a renal mass of malignant appearance, a laparoscopic radical nephrectomy was performed. The pathology report confirmed a mucinous tubular and spindle-cell carcinoma. Mucinous tubular and spindle-cell carcinoma is considered a histological type within renal carcinomas, of low malignancy potential although there are reports that show a more aggressive development. Immunohistochemistry is essential for diagnosis. The case presented has progressed satisfactorily along the 15 months of followup after the radical nephrectomy, being the only treatment.


REFERENCES

  1. Ozturk H. (18) F-fluorodeoxyglucose-positronemission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney. Indian J Nucl Med. 2015 [acceso: 20/01/2020]; 30(1):68-71. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/

  2. López-Beltrán A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006 [acceso: 18/01/2020]; 49(5):798-805. Disponible en: https://www.sciencedirect.com/science/article /abs/pii/S0302283805008316.

  3. Kubota M, Yamasaki T, Teramoto Y, Ito K, Takada H, Magaribuchi T, et al. Two Cases of Metastatic and Recurrent Non-Clear Cell Renal Cell Carcinoma Re-Diagnosed as Renal Mucinous Tubular and Spindle Cell Carcinoma during Long- Term Follow-Up. Hinyokika Kiyo Acta Urol Jap. 2018 [acceso: 20/01/2020]; 64(3):111-5. Disponible en: https://europepmc.org/abstract/med/2968496 0

  4. Kenney PA, Vikram R, Prasad SR, Tamboli P, Matin SF, Wood CG, et al. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes. BJU Int. 2015 [acceso: 11/01/2020]; 116(1):85-92. Disponible en https://www.ncbi.nlm.nih.gov/pubmed

  5. Gaafar A, Valentí C, Echevarria C, Laforga JB, López JI. Renal mucinous and tubular spindle cell carcinoma: a clinicopathological study of 4 cases. Ann Saudi Med. 2006 [acceso: 18/01/2020]; 26(6):466-70. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/173963 79

  6. Kasahara R, Nakaigawa N, Yokomizo Y, Hasumi H, Hayashi N, Muraoka K, et al. Mucinous tubular and spindle cell carcinoma succesfully controled by temisirolimus: a case report. Nihon Hinyokika Gakkai Zasshi. 2017 [acceso: 11/01/2020]; 108(3):149-53. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed

  7. Furuya S, Manabe O, Nanbu T, Yamashita N, Shinnno Y, Kasai K, et al. Renal mucinous tubular and spindle cell carcinoma shows a high uptake on (18)F-FDG PET/CT. Intern Med. 2018 [acceso: 11/01/2020]; 57(8):1131-4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C5938505/

  8. Ren Q, Wang L, Al-Ahmadie HA, Fine SW, Gopalan A, Sirintrapun SJ, et al. Distinct genomic copy number alterations distinguish mucinous tubular and spindle cell carcinoma of the kidney from papillary renal cell carcinoma with overlapping histologic features. Am J Surg Pathol. 2018 [acceso: 18/01/2020]; 42(6):767- 77. Disponible en.: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C6685145/

  9. Kitajima K, Yamamoto S, Kawanaka Y, Katsuura T, Fujita M, Nakanishi Y, et al. Imaging of renal cell carcinoma in patients with acquired cystic disease of the kidney: comparison Ccholine and FDG PET/CT with dynamic contrastenhanced CT. Jpn J Radiol. 2019 [acceso: 18/01/2020]; 37(2):165-77. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/303779 36

  10. Paschos KA, Chatziaggelou A, Chatzigeorgiadis A. Primary collision renal tumor of papillary renal cell carcinoma within an oncocytoma: emergency presentation of a rare entity. Hippokratia. 2017 [acceso: 18/01/2020]; 21(2):105-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C6239085/

  11. Huang ZX, Zhang XP, Dong S, Liu SJ, Yang RL, Zhou YS, et al. Renal mucinous tubular and spindle cell carcinoma combined with multiple bone metastasis: a case report and literature review. Beijing Da Xue Xue Bao Yi Xue Ban. 2018 [acceso: 11/01/2020]; 50(4):732-6. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/

  12. Mikami H, Endo Y, Yanagi M, Nemoto K, Hamasaki T, Kimura G, et al. Laparoscopic lymphadenectomy for postoperative lymphnode metastasis of renal mucinous tubular and spindle cell carcinoma: a case report. Nihon Hinyokika Gakkai Zasshi. 2017 [acceso: 20/01/2020]; 108(1):30-4. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/

  13. Takahashi Y, Numakura K, Aoyama Y, Okada S, Saito T, Muto Y, et al. Metastatic mucinous tubular and spindle cell carcinoma treated with nivolumab successfully : a case report. Hinyokika Kiyo Acta Urol Jap. 2019 [acceso: 20/01/2020]; 65(9):363-7. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/

  14. Du J-H, Zhang L, Liang C-Z. Huge mucinous tubular and spindle cell carcinoma of kidney: A rare case report and literature review. Medicine (Baltimore). 11 [acceso: 20/01/2020]; 97(43):e12933. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C6221687/

  15. Ziouani O, Elalaoui A, Elbote H, Belhabib S, El Sayegh H, Iken A, et al. Mucinous tubular and spindle cell carcinoma: a rare renal tumor. Pan Afr Med J. 2017 [acceso: 20/01/2020]; 26:187. Disponible en.: https://www.ncbi.nlm.nih.gov/pubmed/286745 80

  16. Song HJ, Ma J, Zhou HB, Ma HH, Shi QL, Zhou XJ. Mucinous tubular and spindle cell carcinoma of kidney: a clinicopathological study. Zhonghua Bing Li Xue Za Zhi. 2011 [acceso: 20/01/2020]; 40(7):444-8. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22088369




2020     |     www.medigraphic.com